When treated with proanthocyanidins, bioactive compounds derived from the fruits of the American cranberry (Vaccinium macrocarpon), human pathogens Escherichia coli, Proteus mirabilis, and Pseudomonas aeruginosa become more sensitive to lower doses of antibiotics, according to a new study published in the journal Advanced Science. What’s more, the pathogenic bacteria don’t develop resistance to the antibiotics. Maisuria et al demonstrated that...
